Phase 1 Trial of Betalutin, a Radioimmunotherapy, in Advanced DLBCL Now Fully Enrolled
News
The Phase 1 trial evaluating Betalutin — an investigational tumor-targeting antibody labeled with a type of radiation — in people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is now fully ... Read more